Innovid Corp. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 1 months to Dec 31, 2020
Formation and operating costs
Revenue
Cost of revenues
Gross profit
Research and development
Sales and marketing
General and administrative
Total operating expenses
Depreciation, amortization and long-lived assets impairment
Goodwill impairment
Operating loss
Finance expenses, net
Finance (income) expenses, net
Loss before taxes
Taxes on income
Net loss
Weighted average shares outstanding, basic and diluted (in Shares)
Basic and diluted net loss per ordinary share (in Dollars per share)
Accretion of preferred stock to redemption value
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Net loss per stock attributable to common stockholders
Net loss per share attributable to common stockholders – basic (in dollars per share)
Net loss per share attributable to common stockholders – diluted (in dollars per share)
Weighted-average number of shares used in computing net loss per share attributable to common stockholders
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic (in shares)
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted (in shares)
Exchange ratio

Comments